|
|
|
|
The Anatomical Therapeutic Chemical (ATC) classification system
|
|
|
|
|
|
Level 5
L - Antineoplastic and immunomodulating agentsL04 - Immunosuppressive agentsL04A - Immunosuppressive agentsL04AA - Selective immunosuppressive agentsL04AA16 - Afelimomab
Afelimomab
|
|
|
|